New York, NY, and Tel Aviv, ISRAEL, Nov. 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos…
ANAHEIM, CA, Nov. 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”),…
VUMERITY is a next-generation oral fumarate treatment for people with relapsing-remitting MS with established efficacy…
CHICAGO, Nov. 16, 2021 (GLOBE NEWSWIRE) — Cosmos Holdings, Inc. (“the Company”) (OTCQX: COSM), an…
WOBURN, MA, Nov. 16, 2021 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a…
Robust SARS-CoV-2 sequencing kit and upgraded microbial whole genome assembly workflow enable public health laboratories…
Company develops COVID-19 “Correlate of Protection” research to measure levels of neutralizing antibodies which protect…
WALTHAM, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing…
EDISON, N.J., Nov. 16, 2021 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage…
– Broader Indication to Include Smallpox, Monkeypox, Cowpox, and Vaccinia Complications – NEW YORK, Nov….
VANCOUVER, British Columbia, Nov. 16, 2021 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSXV: RKV) (“the…
-Initiation of patient enrollment expected by year-end- ZUG, Switzerland and CAMBRIDGE, Mass. and SAN DIEGO,…
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) — VistaGen Therapeutics, Inc. (NASDAQ: VTGN),…
AGOURA HILLS, CA, Nov. 16, 2021 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic” or the…
YARDLEY, Pa., Nov. 16, 2021 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on…
Assay developed using Abyssinia proprietary antibodies shows promise as sensitive and specific companion diagnostic Further…
With 25+ years of experience, Dr. Scaria has led numerous gene therapy programs from early…
Plans to submit an IND to support a Phase 2b clinical trial for COYA101 HOUSTON,…
SOTIO Biotech licenses LegoChem Biosciences (LCB) technology for five new antibody-drug conjugate (ADC) programs Rights…
SAN DIEGO, Nov. 16, 2021 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision…